Softwr

Healthcare · head to head

Philips IntelliSpace PACS vs Woebot Health

Philips IntelliSpace PACS logo

Philips IntelliSpace PACS

Healthcare

Enterprise radiology PACS and diagnostic image viewing from Philips

From
On request
Rated
-
Woebot Health logo

Woebot Health

Healthcare

Conversational CBT chatbot that withdrew from consumer distribution and now sells only to payers and providers

From
On request
Rated
-

The short version

  • Each has a real cost: Philips IntelliSpace PACS philips has consolidated its imaging marketing under Philips Enterprise Imaging and several IntelliSpace PACS regional pages now redirect to a generic medical imaging page, so a buyer signing a long PACS term should demand a written product lifecycle and version support statement before committing.; Woebot Health the company withdrew its consumer app in June 2025 after concluding FDA marketing authorisation was not achievable at acceptable cost, which is a plain signal about both regulatory position and commercial durability.
  • They diverge on capability: Philips IntelliSpace PACS covers Diagnostic reading client, Woebot Health covers Scripted CBT dialogue.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Philips IntelliSpace PACS and Woebot Health actually diverge.

Attributes where Philips IntelliSpace PACS and Woebot Health differ
AttributePhilips IntelliSpace PACSWoebot Health
PlatformsWeb, WindowsiOS, Android, Web

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Philips IntelliSpace PACS

  • Diagnostic reading client
  • Zero footprint web viewer
  • Enterprise archive
  • Advanced visualisation
  • IntelliSpace Radiology on AWS
  • Worklist and workflow
  • AI results integration

Only in Woebot Health

  • Scripted CBT dialogue
  • Mood tracking
  • Crisis routing
  • Between-session support
  • Payer deployment
  • Provider copilot positioning
  • Research licensing
  • Population reporting

What people use each for

The jobs each tool is most often brought in to do.

Philips IntelliSpace PACS

  • A hospital replacing an end of life PACS that already runs a large Philips CT and MR estate and wants modality and reading integration in one support contractnot Woebot Health
  • A radiology group consolidating several departmental archives into one enterprise archive with a single radiologist worklistnot Woebot Health
  • A health system that wants to move diagnostic reading off local workstations into a cloud hosted environment via the AWS listingnot Woebot Health
  • Sites that need server side advanced visualisation so radiologists can do 3D and vessel work without dedicated 3D workstationsnot Woebot Health

Woebot Health

  • A health plan wanting a low intensity behavioural health option for members on a waiting list for therapynot Philips IntelliSpace PACS
  • A provider organisation offering structured between-session CBT practice to patients already in treatmentnot Philips IntelliSpace PACS
  • A research group running a trial that needs a clinically scripted rather than generative conversational agent for safety reasonsnot Philips IntelliSpace PACS
  • A payer targeting a specific population such as postpartum members where scripted CBT content already existsnot Philips IntelliSpace PACS

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Philips IntelliSpace PACS

  • Philips has consolidated its imaging marketing under Philips Enterprise Imaging and several IntelliSpace PACS regional pages now redirect to a generic medical imaging page, so a buyer signing a long PACS term should demand a written product lifecycle and version support statement before committing.
  • Advanced visualisation is licensed by concurrent user separately from the base PACS, so a department that sizes concurrency from average use finds radiologists blocked at the morning peak and buys more licences after go live.
  • The deepest integration is with Philips modalities, so sites running mixed GE and Siemens scanner fleets get less of the workflow benefit than the demonstration environment implies.
  • Third party AI findings arrive through a results interface rather than natively in the hanging protocol, so radiologists context switch to see algorithm output and adoption of purchased AI is lower than expected.
  • Data migration from a legacy PACS is a separate, large and often underquoted professional services line, and migrations of a decade of priors routinely run longer than the go live plan allows.

Woebot Health

  • The company withdrew its consumer app in June 2025 after concluding FDA marketing authorisation was not achievable at acceptable cost, which is a plain signal about both regulatory position and commercial durability.
  • It is not an FDA cleared treatment for any indication, so it cannot be positioned to members as therapy and cannot substitute for a covered behavioural health benefit.
  • The scripted, non-generative design that makes it safe also makes it feel rigid next to current conversational AI, and engagement drops off quickly once users hit the edges of the script.
  • Published evidence is short-horizon symptom change in selected populations, mostly young adults, with little evidence of durable benefit or effect at whole-population scale.
  • With consumer distribution gone, the remaining business depends on a small number of payer and provider contracts, so a buyer should assume real vendor continuity risk over a multi-year term.

Pricing, plan by plan

Philips IntelliSpace PACS

On request
  • IntelliSpace PACS$undefined/year
    • Priced by annual study volume and concurrent diagnostic users
    • Advanced visualisation licensed separately by concurrent user
    • Storage and archive tiering priced by capacity

Woebot Health

On request
  • Woebot for payers and providers$undefined/year
    • Contracted per member per month or as a population licence
    • Sold to health plans and provider organisations, not to employers or individuals
    • No consumer purchase route since the app closed in June 2025

Which should you pick?

Choose Philips IntelliSpace PACS if

  • You need diagnostic reading client.
  • You work on Web, Windows.
  • You also want zero footprint web viewer.

Choose Woebot Health if

  • You need scripted cbt dialogue.
  • You work on iOS, Android, Web.
  • You also want mood tracking.

Questions people ask

Is Philips IntelliSpace PACS or Woebot Health better?
Neither clearly leads. Philips IntelliSpace PACS starts at On request and Woebot Health at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Philips IntelliSpace PACS or Woebot Health?
Philips IntelliSpace PACS starts at On request and Woebot Health at On request.
Does Philips IntelliSpace PACS or Woebot Health run on more platforms?
Philips IntelliSpace PACS runs on Web, Windows. Woebot Health runs on iOS, Android, Web.
What is Philips IntelliSpace PACS best used for?
Philips IntelliSpace PACS is most often used for a hospital replacing an end of life pacs that already runs a large philips ct and mr estate and wants modality and reading integration in one support contract, a radiology group consolidating several departmental archives into one enterprise archive with a single radiologist worklist, a health system that wants to move diagnostic reading off local workstations into a cloud hosted environment via the aws listing, sites that need server side advanced visualisation so radiologists can do 3d and vessel work without dedicated 3d workstations. Of those, a hospital replacing an end of life pacs that already runs a large philips ct and mr estate and wants modality and reading integration in one support contract and a radiology group consolidating several departmental archives into one enterprise archive with a single radiologist worklist are not what Woebot Health is typically brought in for.
What can Philips IntelliSpace PACS do that Woebot Health cannot?
Philips IntelliSpace PACS covers Diagnostic reading client, Zero footprint web viewer, Enterprise archive, Advanced visualisation. Woebot Health covers Scripted CBT dialogue, Mood tracking, Crisis routing, Between-session support.

Answered from the vendors’ own pages

Philips IntelliSpace PACS: Is IntelliSpace PACS being discontinued?

It is still sold and supported, but Philips has moved its marketing to Philips Enterprise Imaging and some regional IntelliSpace product pages now redirect. Ask Philips for the written lifecycle statement before signing a multi year term.

Woebot Health: Is Woebot still available?

Not to consumers. The consumer app closed in June 2025. The company continues to offer the product to payers, providers and researchers.

Philips IntelliSpace PACS: Can I run it in the cloud?

Yes. Philips lists IntelliSpace Radiology on AWS Marketplace, and Philips also offers a managed hosted deployment. Both are quoted rather than self service.

Woebot Health: Is it FDA cleared?

No. It held Breakthrough Device designation but never obtained marketing authorisation, and the founder cited the cost of that pathway as the reason for closing the consumer app.

Philips IntelliSpace PACS: Does Philips publish pricing?

No. Pricing is by study volume, concurrent diagnostic users and storage, and is usually negotiated alongside modality capital.

Woebot Health: Is it generative AI?

Historically no. The dialogue is clinician-written and rule-based, a deliberate safety choice that limits how naturally it converses.

Philips IntelliSpace PACS: Will it read images from non Philips scanners?

Yes, it is a standard DICOM archive and viewer. The gap is in advanced visualisation and modality workflow integration, which is deeper on Philips equipment.

Woebot Health: What does the evidence show?

Randomised studies reported reduced depressive symptoms over short periods in selected populations, notably young adults. That is symptom change in a trial, not demonstrated population outcomes.

Share

Related pages

Other head to heads